<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6547">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01907503</url>
  </required_header>
  <id_info>
    <org_study_id>Maillefert PHRC R 2004</org_study_id>
    <nct_id>NCT01907503</nct_id>
  </id_info>
  <brief_title>Adaptation of Locomotor Activity in Patients Suffering From Hip OA - Analysis of This Adaptation as a Prognostic Criterion for Future Disease Progression</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <authority>France: Direction Générale de la Santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the prognostic value of a characteristic evaluation of gait in persons suffering
      from hip OA for subsequent indications for THR.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2008</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>locomotor activity</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Primary Hip Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Patients with Primary hip osteoarthritis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients with Primary hip osteoarthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy volunteer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Evaluation of the balance of force platform</intervention_name>
    <arm_group_label>Patients with Primary hip osteoarthritis</arm_group_label>
    <arm_group_label>Healthy volunteer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women aged between 45 and 75 years Suffering from primary hip osteoarthritis
             defined according to ACR criteria who presented pain in the hip for at least one
             month in the preceding 3 months Radiological stage II, III or IV hip OA according to
             the Kellgren and Lawrence classification Patients able to understand simple
             instructions des packaging instructions, to give their written informed consent.

        Exclusion Criteria:

          -  Indication for THR at the time of inclusion. Pregnant or breast-feeding women
             Alzheimer's disease Chronic respiratory insufficiency with clinical manifestations
             Parkinson's disease Motor neuron disease Major musculo-skeletal disorder (other than
             hip OA) Severe non-stabilised diabetes Non-stabilised hypertension Hip OA
             inflammation flare Rapidly-destructive hip OA Radiography to evaluate structural
             evolution of the disease done more than 12 months previously Presence of OA in
             another joint, or another osteoarticular or periarticular disease of the lower limbs
             with, in the opinion of the patient, disability due to this other disease that is
             greater than the disability caused by the hip OA.

        Spine disease causing gait disturbance  (radiculalgia, lumbar canal stenosis,… with, in
        the opinion of the patient, disability due to this other disease that is greater than the
        disability caused by the hip OA.)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maud CARPENTIER</last_name>
      <phone>03.80.29.35.10</phone>
      <email>maud.carpentier@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-francis Maillefert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 24, 2013</lastchanged_date>
  <firstreceived_date>July 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
    <mesh_term>Disease Progression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
